Human induced pluripotent stem cell-derived hepatocytes for toxicology testing

Bibliography

• Frank C, Himmelstein DU, Woolhandler S, et al. Era of faster FDA drug approval has also seen increased black-box warnings and market withdrawals. Health Aff 2014;33(8):1453-9
   Web of Science ®Google Scholar
• Khan JM, Lyon AR, Harding SE. The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening. Br J Pharmacol 2013;169:304-17
   PubMed Web of Science ®Google Scholar
• Sager PT, Gintant G, Turner JR, et al. Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium. Am Heart J 2014;167(3):292-300
   PubMed Web of Science ®Google Scholar
• Clayton RF, Rinaldi A, Kandyba EE, et al. Liver cell lines for the study of hepatocyte functions and immunological response. Liver Int 2005;25(2):389-402
   PubMed Web of Science ®Google Scholar
• Liguori MJ, Blomme EA, Waring JF. Trovafloxacin-induced gene expression changes in liver-derived in vitro systems: comparison of primary human hepatocytes to HepG2 Cells. Drug Metab Dispos 2008;36:223-33
   PubMed Web of Science ®Google Scholar
• Aninat C, Piton A, Glaise D, et al. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos 2006;34:75-83
   PubMed Web of Science ®Google Scholar
• LeCluyse EL, Alexandre E, Hamilton GA, et al. Isolation and culture of primary human hepatocytes. Methods Mol Biol 2005;290:207-29
   PubMedGoogle Scholar
• Dunn JC, Yarmush ML, Koebe HG, et al. Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J 1989;3(2):174-7
   PubMed Web of Science ®Google Scholar
• Swifta B, Pfeifera ND, Brouwer KL. Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 2010;42(3):446-71
   PubMed Web of Science ®Google Scholar
• Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324(5928):797-801
   PubMed Web of Science ®Google Scholar
• Sullivan GJ, Hay DC, Park IH, et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010;51(1):329-35
   PubMed Web of Science ®Google Scholar
• Si-Tayeb K, Noto FK, Nagaoka M, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010;51(1):297-305
   PubMed Web of Science ®Google Scholar
• Ulvestad M, Nordell P, Asplund A, et al. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells. Biochem Pharmacol 2013;86:691-702
   PubMed Web of Science ®Google Scholar
• Ma X, Duan Y, Tschudy-Seney B, et al. Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells. Stem Cell Transl Med 2013;2:409-19
   PubMed Web of Science ®Google Scholar
• Hannan NR, Segeritz C-P, Touboul T, et al. Production of hepatocyte-like cells from human pluripotent stem cells. Nat Protoc 2013;8(2):430-7
   PubMed Web of Science ®Google Scholar
• Medine CN, Lucendo-Villarin B, Storck C, et al. Developing high-fidelity hepatotoxicity models from pluripotent stem cells. Stem Cells Transl Med 2013;2(7):505-9
   PubMed Web of Science ®Google Scholar
• Sirenko O, Hesley J, Rusyn I, et al. High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells. Assay Drug Dev Technol 2014;12(1):43-54
   PubMed Web of Science ®Google Scholar
• Szkolnicka D, Farnworth SL, Lucendo-Villarin B, et al. Accurate prediction of drug-induced liver injury using stem cell-derived populations. Stem Cells Transl Med 2014;3(2):141-8
   PubMed Web of Science ®Google Scholar
• Holmgren G, Sjögren AK, Barragan I, et al. Long-term chronic toxicity testing using human pluripotent stem cell–derived hepatocytes. Drug Metab Dispos 2014;42(9):1401-6
   PubMed Web of Science ®Google Scholar
• Kia R, Sison RLC, Heslop J, et al. Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet? Br J Clin Pharmacol 2013;75(4):885-96
   PubMed Web of Science ®Google Scholar
• Urban TJ, Goldstein DB, Watkins PB. Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here? Pharmacogenomics 2012;13(7):735-8
   PubMed Web of Science ®Google Scholar
• Shan J, Schwartz RE, Ross NT, et al. Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol 2013;9:514-20
   PubMed Web of Science ®Google Scholar
• Khetani SR, Bhatia SN. Microscale culture of human liver cells for drug development. Nat Biotechnol 2008;26(1):120-6
   PubMed Web of Science ®Google Scholar
• Dash A, Simmers MB, Deering TG, et al. Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro. Am J Physiol Cell Physiol 2013;304(11):C1053-63
   PubMed Web of Science ®Google Scholar
• Hay DC, Pernagallo S, Diaz-Mochon JJ, et al. Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism. Stem Cell Res 2011;6(2):92-102
   PubMed Web of Science ®Google Scholar
• Hay DC. Rapid and scalable human stem cell differentiation: now in 3D. Stem Cells Dev 2013;22(20):2691-2
   PubMed Web of Science ®Google Scholar
• Ogawa S, Surapisitchat J, Virtanen C, et al. Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development 2013;140:3285-96
   PubMed Web of Science ®Google Scholar
• Takebe T, Sekine K, Enomura M, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 2013;499:481-4
   PubMed Web of Science ®Google Scholar